<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Condo et al. determined that clove EO was active against pathogenic strains, such as 
 <italic class="italic">Aeromonas hydrophila</italic> ATCC 7966 (IZr of 8 mm), 
 <italic class="italic">Candida albicans</italic> ATCC 10231 (IZr of 7 mm), and 
 <italic class="italic">Proteus mirabilis</italic> ATCC 10005 (IZr of 6 mm), while it showed a weaker effect against 
 <italic class="italic">Escherichia coli</italic> ATCC 8739, 
 <italic class="italic">Klebsiella pneumoniae</italic> ATCC 13883, 
 <italic class="italic">Pseudomonas aeruginosa</italic> ATCC 27853, 
 <italic class="italic">Staphylococcus aureus</italic> ATCC 6538, and 
 <italic class="italic">Staphylococcus epidermidis</italic> ATCC 14990 [
 <xref rid="B88-molecules-24-02130" ref-type="bibr" class="xref">88</xref>]. Clove EO also inhibits the development of microorganisms. such as 
 <italic class="italic">Bacilus subtilis, Morganella morganii</italic> [
 <xref rid="B10-molecules-24-02130" ref-type="bibr" class="xref">10</xref>] 
 <italic class="italic">Mycobacterium phlei, Aspergillus niger</italic>, and 
 <italic class="italic">Penicillum christopherum</italic> [
 <xref rid="B84-molecules-24-02130" ref-type="bibr" class="xref">84</xref>].
</p>
